XOMA Adds Economic Interests in Three First-in-Category Assets to its[...]
Cero Therapeutics Holdings Inc.
TIM-4-L-targeting CER-1236 Engineered T cells Eliminate Adverse-Risk[...]
04/17/2024 | Press release | Distributed by Public on 04/17/2024 16:02
Please select the service you want to use:
Smartlinks | Avidbank Holdings Inc. | News | Local News | Company News | Top Company News | Financial Services | Banking | Securities Issuers | Banks | OTC Markets
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact